Related Experiment Video
Updated: Jul 7, 2026

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
Published on: March 9, 2019
Enhancing safety with potassium phosphates injection
Patti Cornish1, Sylvia Hyland, Christine Koczmara
1Patient Safety Service, Sunnybrook Health Sciences Centre.
Abstract:
The inadvertent administration of concentrated potassium chloride resulting in patient death is well-documented in Canada and other countries. Vials of potassium phosphates contain more than twice the concentration of potassium compared to vials of potassium chloride concentrate. If inadequately diluted or administered too rapidly, intravenous potassium phosphate can also lead to serious patient harm. This article contains information reprinted with permission from an ISMP Canada Safety Bulletin (ISMP Canada, 2006, April 25) for the purpose of enhancing safety with potassium phosphates injection.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Depolarizing Blockers: Pharmocokinetics
Antihypertensive Drugs: Potassium-Sparing Diuretics
